Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...
Newsable Asianet News on MSN
IIT Kanpur researchers solve mystery of immune receptor C5aR2's function
IIT Kanpur researchers, led by Professor Arun K Shukla, used cryo-EM to uncover the molecular basis of the atypical immune receptor C5aR2. They revealed its unique structure and developed a molecule ...
Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it ...
IIT Kanpur researchers solve mystery of atypical drug target receptor ...
IIT Kanpur scientists have unlocked the mystery behind the C5aR2 immune receptor's unique function. Using advanced cryo-EM, ...
New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...
2hon MSN
Meet GHK-Cu, the Copper Peptide Taking Over Your Skincare Feed—Here's Whether It's Worth the Hype
Meet GHK-Cu, the Copper Peptide Taking Over Your Skincare Feed—Here's Whether It's Worth the Hype ...
MedPage Today on MSN
NEJM Retracts Pivotal Trial of FDA-Approved Drug
Move follows actions "inconsistent with proper research conduct," journal says ...
The EMA says the benefits of Tavneos no longer outweigh the risks for the treatment of active granulomatosis with polyangiitis.
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the European Medicines Agency's (EMA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results